NORTHWEST BIOTHERAPEUTICS INC

Northwest Biotherapeutics Inc.

Biotechnology • Healthcare • Bethesda, MD, United States • NWBO (OQB)

Northwest Biotherapeutics, Inc., a biotechnology company, focuses on developing personalized immune therapies for cancer. The company develops DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product candidate is the DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, that has completed Phase I clinical trials to treat inoperable solid tumors, as well as a range of types of cancers. Northwest Biotherapeutics, Inc. was founded in 1996 and is headquartered in Bethesda, Maryland.

240 497 9024 4800 Montgomery Lane, Bethesda, MD 20814, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Northwest Biotherapeutics (OTCMKTS:NWBO) Shares Gap Up - What's Next? - MarketBeat
MarketBeat • Jan 6
Northwest Biotherapeutics Expands Authorized Common Stock Capacity - The Globe and Mail
The Globe and Mail • Jan 3
Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd. - PR Newswire
PR Newswire • Aug 27
Northwest Biotherapeutics shareholders approve board election and share increase By Investing.com - Investing.com Nigeria
Investing.com Nigeria • Jan 2
Northwest Biotherapeutics (NWBO) proxy seeks 2.6B share authorization and say-on-pay - Stock Titan
Stock Titan • Nov 28

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has NORTHWEST BIOTHERAPEUTICS INC had layoffs?
No layoff events have been recorded for NORTHWEST BIOTHERAPEUTICS INC in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does NORTHWEST BIOTHERAPEUTICS INC have?
NORTHWEST BIOTHERAPEUTICS INC has approximately 25 employees.
What industry is NORTHWEST BIOTHERAPEUTICS INC in?
NORTHWEST BIOTHERAPEUTICS INC operates in the Biotechnology industry, within the Healthcare sector.
Is NORTHWEST BIOTHERAPEUTICS INC a publicly traded company?
Yes, NORTHWEST BIOTHERAPEUTICS INC is publicly traded under the ticker symbol NWBO on the OQB. The company has a market capitalization of approximately $0.37 billion.
Where is NORTHWEST BIOTHERAPEUTICS INC headquartered?
NORTHWEST BIOTHERAPEUTICS INC is headquartered in Bethesda, MD, United States at 4800 Montgomery Lane, Bethesda, MD 20814, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.